News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Segal Institute for Clinical Research Physician, Steven E. Chavoustie, MD, FACOG, CCRP Co-authors Titan Pharmaceuticals (TTP) Buprenorphine Implant Abstract



12/20/2012 9:33:50 AM

MIAMI--(BUSINESS WIRE)--Segal Institute for Clinical Research, a consortium of psychiatric, addiction, medical and women’s health research sites, proudly congratulates Dr. Steven Chavousite for his co-authorship of the Titan Pharmaceuticals poster abstract, “Buprenorphine Implants for the Treatment of Opioid Dependence: Six and 12 Month Outcomes.”

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES